$9.2M
sold in all offerings
Reprise Biomedical, Inc. is a corporation based in Plymouth, MN in the Biotechnology industry group. From May 21, 2026 to July 1, 2026 it filed 2 private fundraising filings for 1 offering and reported $9.2 million sold in all.
Updated October 10, 2026 · newest filing Jul 1, 2026
Amount sold
$9.2M
All offerings, newest filing of each
Offered
$10.0M
Total amount sought
Offerings
1
2 filings with amendments
Newest offering
$9.2M
Sold, first filed May 21, 2026
Investors
43
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Plymouth, MN
- Industry group
- Biotechnology
- Listed
- No
- First filing
- May 21, 2026
- Newest filing
- July 1, 2026
- Exemptions
- 506(b)
Offerings
1 offering, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| May 21, 2026 | $9.2M | $10.0M | 43 | - | 506(b) | Equity |
Filing history
2 filings, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Jul 1, 2026 | Amendment | $9.2M | $10.0M | 43 |
| May 21, 2026 | New offering | $1.4M | $8.0M | 4 |
Related pages
Questions and answers
How much has Reprise Biomedical, Inc. raised in private offerings?
$9.2 million sold in 1 private offering reported from May 21, 2026 to Jul 1, 2026, counting each offering once at its newest filing.
When did Reprise Biomedical, Inc. last file about a private offering?
July 1, 2026. Its newest offering reported $9.2 million sold of $10 million offered to 43 investors.
Which exemption does Reprise Biomedical, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is Reprise Biomedical, Inc. a listed company?
No ticker is linked to this issuer, so it is private or no longer listed.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.